164 related articles for article (PubMed ID: 1124788)
21. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
[TBL] [Abstract][Full Text] [Related]
22. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
[TBL] [Abstract][Full Text] [Related]
23. The renal and hemodynamic effects of furosemide in acute myocardial infarction.
Nishimura N; Kanbe N
Crit Care Med; 1981 Dec; 9(12):829-32. PubMed ID: 7318454
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of acute renal failure with high doses of Furosemide Polfa].
Rancewicz Z; Rowińska D; Lao M
Pol Arch Med Wewn; 1972 Feb; 49(2):187-95. PubMed ID: 4670217
[No Abstract] [Full Text] [Related]
25. Furosemide as a functional marker of acute kidney injury in ICU patients: a new role for an old drug.
Mariano F; Mella A; Vincenti M; Biancone L
J Nephrol; 2019 Dec; 32(6):883-893. PubMed ID: 31090022
[TBL] [Abstract][Full Text] [Related]
26. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
27. Does Furosemide Increase Oxidative Stress in Acute Kidney Injury?
Silbert BI; Ho KM; Lipman J; Roberts JA; Corcoran TB; Morgan DJ; Pavey W; Mas E; Barden AE; Mori TA
Antioxid Redox Signal; 2017 Feb; 26(5):221-226. PubMed ID: 27530232
[TBL] [Abstract][Full Text] [Related]
28. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
[TBL] [Abstract][Full Text] [Related]
29. Renal hemodynamics and medullary osmolal gradient in ischemic acute renal failure in rabbits.
Nihei H; Honda N; Suzuki K; Nagase M; Yoshitoshi Y
Jpn Heart J; 1975 Jan; 16(1):44-56. PubMed ID: 1113448
[TBL] [Abstract][Full Text] [Related]
30. Continuous intravenous furosemide in haemodynamically unstable children after cardiac surgery.
van der Vorst MM; Ruys-Dudok van Heel I; Kist-van Holthe JE; den Hartigh J; Schoemaker RC; Cohen AF; Burggraaf J
Intensive Care Med; 2001 Apr; 27(4):711-5. PubMed ID: 11398698
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
Swärd K; Valsson F; Sellgren J; Ricksten SE
Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
[TBL] [Abstract][Full Text] [Related]
32. Furosemide in acute oliguric renal failure. A controlled trial.
Kleinknecht D; Ganeval D; Gonzalez-Duque LA; Fermanian J
Nephron; 1976; 17(1):51-8. PubMed ID: 778649
[TBL] [Abstract][Full Text] [Related]
33. Effects of ventriculoarterial coupling changes on renal function, echocardiographic indices and energy efficiency in patients with acute decompensated systolic heart failure under furosemide and dopamine treatment: a comparison of three therapeutic protocols.
Antoniou CK; Chrysohoou C; Lerakis S; Manolakou P; Pitsavos C; Tsioufis K; Stefanadis C; Tousoulis D
Int J Cardiol; 2015 Nov; 199():44-9. PubMed ID: 26186629
[TBL] [Abstract][Full Text] [Related]
34. Failure of loop diuretics to improve the long term outcome of ischaemic damage in rat kidneys.
Källskog O; Nygren K; Wolgast M
Ups J Med Sci; 2001; 106(2):151-60. PubMed ID: 11888071
[TBL] [Abstract][Full Text] [Related]
35. Effects of naloxone infusion in patients with septic shock and renal failure: a limited experience.
Duarte RR; Ali MM; Sayegh NY; Nayak P; Grace BW
Am J Nephrol; 1992; 12(6):431-6. PubMed ID: 1292342
[TBL] [Abstract][Full Text] [Related]
36. The effect of diuretics on renal hemodynamics during cardiopulmonary bypass.
Engelman RM; Gouge TH; Smith SJ; Stahl WM; Gombos EA; Boyd AD
J Surg Res; 1974 Mar; 16(3):268-76. PubMed ID: 4819615
[No Abstract] [Full Text] [Related]
37. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
[TBL] [Abstract][Full Text] [Related]
38. Acute renal effects of high doses of furosemide administered intravenously in patients with advanced chronic renal insufficiency.
Radò JP; Juhos E; Szende L; Marosi J; Takò J; Salamon F
J Med; 1973; 4(4):219-32. PubMed ID: 4520349
[No Abstract] [Full Text] [Related]
39. Determinants of Urinary Output Response to IV Furosemide in Acute Kidney Injury: A Pharmacokinetic/Pharmacodynamic Study.
Silbert BI; Ho KM; Lipman J; Roberts JA; Corcoran TB; Morgan DJ; Pavey W; Mas E; Barden AE; Mori TA
Crit Care Med; 2016 Oct; 44(10):e923-9. PubMed ID: 27183025
[TBL] [Abstract][Full Text] [Related]
40. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
